chr2-177817928-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016953.4(PDE11A):​c.1577-3T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.316 in 1,396,904 control chromosomes in the GnomAD database, including 75,446 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 14371 hom., cov: 31)
Exomes 𝑓: 0.31 ( 61075 hom. )

Consequence

PDE11A
NM_016953.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00004978
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.41

Publications

18 publications found
Variant links:
Genes affected
PDE11A (HGNC:8773): (phosphodiesterase 11A) The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PDE11A Gene-Disease associations (from GenCC):
  • pigmented nodular adrenocortical disease, primary, 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine
  • primary pigmented nodular adrenocortical disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-177817928-A-G is Benign according to our data. Variant chr2-177817928-A-G is described in ClinVar as [Benign]. Clinvar id is 1327001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.638 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDE11ANM_016953.4 linkc.1577-3T>C splice_region_variant, intron_variant Intron 7 of 19 ENST00000286063.11 NP_058649.3 Q9HCR9-1
PDE11ANM_001077197.2 linkc.827-3T>C splice_region_variant, intron_variant Intron 8 of 20 NP_001070665.1 Q9HCR9-2
PDE11ANM_001077358.2 linkc.503-3T>C splice_region_variant, intron_variant Intron 6 of 18 NP_001070826.1 Q9HCR9-3
PDE11ANM_001077196.2 linkc.245-3T>C splice_region_variant, intron_variant Intron 4 of 16 NP_001070664.1 Q9HCR9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDE11AENST00000286063.11 linkc.1577-3T>C splice_region_variant, intron_variant Intron 7 of 19 1 NM_016953.4 ENSP00000286063.5 Q9HCR9-1

Frequencies

GnomAD3 genomes
AF:
0.406
AC:
61646
AN:
151786
Hom.:
14355
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.644
Gnomad AMI
AF:
0.524
Gnomad AMR
AF:
0.310
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.319
Gnomad SAS
AF:
0.332
Gnomad FIN
AF:
0.235
Gnomad MID
AF:
0.452
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.420
GnomAD2 exomes
AF:
0.324
AC:
81066
AN:
250122
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.648
Gnomad AMR exome
AF:
0.208
Gnomad ASJ exome
AF:
0.381
Gnomad EAS exome
AF:
0.314
Gnomad FIN exome
AF:
0.234
Gnomad NFE exome
AF:
0.323
Gnomad OTH exome
AF:
0.333
GnomAD4 exome
AF:
0.305
AC:
380217
AN:
1245000
Hom.:
61075
Cov.:
20
AF XY:
0.308
AC XY:
194133
AN XY:
630134
show subpopulations
African (AFR)
AF:
0.640
AC:
17523
AN:
27366
American (AMR)
AF:
0.219
AC:
9728
AN:
44406
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
9182
AN:
24620
East Asian (EAS)
AF:
0.298
AC:
11528
AN:
38644
South Asian (SAS)
AF:
0.335
AC:
27409
AN:
81762
European-Finnish (FIN)
AF:
0.238
AC:
12646
AN:
53038
Middle Eastern (MID)
AF:
0.411
AC:
2172
AN:
5288
European-Non Finnish (NFE)
AF:
0.297
AC:
272703
AN:
916994
Other (OTH)
AF:
0.328
AC:
17326
AN:
52882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.435
Heterozygous variant carriers
0
11196
22391
33587
44782
55978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8062
16124
24186
32248
40310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.406
AC:
61704
AN:
151904
Hom.:
14371
Cov.:
31
AF XY:
0.400
AC XY:
29705
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.644
AC:
26661
AN:
41394
American (AMR)
AF:
0.310
AC:
4728
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1336
AN:
3466
East Asian (EAS)
AF:
0.319
AC:
1643
AN:
5152
South Asian (SAS)
AF:
0.332
AC:
1598
AN:
4816
European-Finnish (FIN)
AF:
0.235
AC:
2479
AN:
10556
Middle Eastern (MID)
AF:
0.428
AC:
124
AN:
290
European-Non Finnish (NFE)
AF:
0.321
AC:
21777
AN:
67942
Other (OTH)
AF:
0.417
AC:
880
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1646
3292
4939
6585
8231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.355
Hom.:
20250
Bravo
AF:
0.422
Asia WGS
AF:
0.297
AC:
1035
AN:
3478
EpiCase
AF:
0.339
EpiControl
AF:
0.347

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pigmented nodular adrenocortical disease, primary, 2 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
5.7
DANN
Benign
0.69
PhyloP100
1.4
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000050
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3821010; hg19: chr2-178682655; COSMIC: COSV53695596; API